Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

There are some possible benefits to chilly dunks, but not a ton—and they are mostly without staying power.

Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's ...

Pfizer shares rose early Tuesday due to higher than expected demand for its COVID vaccine, but quickly sunk 2.3% after ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

We evaluated 925 U.S. hospitals based on mortality rates, operational efficiency, patient experience, and more.

Before the U-turn on tariffs, Goldman Sachs said “there is a substantial probability that the tariffs on Canada and Mexico ...

Tesla’s stock fell 5% on Monday, the biggest drop for any member of the so-called “Magnificent Seven,” while Apple shares ...

DeepSeek has tilted the market in favor of open source, but major security concerns remain.

The tech juggernaut wants to field communication skills without help from tech, and Anthropic isn’t the only employer pushing ...

This is a “really big year” for Meta, CEO Mark Zuckerberg said last week.

The agency also represents the production company Higher Ground—fronted by Barack Obama and his wife Michelle.